Patents by Inventor Henrik Aggerbeck

Henrik Aggerbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Skin testing for tuberculosis in immunocompromised persons
    Patent number: 10786579
    Abstract: Disclosed herein is the use of Mycobacterium tuberculosis antigens for use in in vivo determination of the presence of Mtb infection in immunocompromised persons or persons co-infected with HIV and the for preparing a diagnostic reagent for skin testing (a skin test reagent) for robust assessment of the presence of Mtb infection infection in an individual wherein the individual is an immunocompromised person or a person co-infected with HIV.
    Type: Grant
    Filed: November 15, 2016
    Date of Patent: September 29, 2020
    Assignee: Statens Serum Institut
    Inventors: Henrik Aggerbeck, Peter Lawætz Andersen, Morten Ruhwald
  • Skin Testing for Tuberculosis in Immunocompromised Persons
    Publication number: 20190151479
    Abstract: The present invention discloses the use of Mycobacterium tuberculosis antigens for use in in vivodetermination of the presence of Mtbinfection in immunocompromised persons or persons co-infected with HIVand the for preparing a diagnostic reagent for skin testing (a skin test reagent) for robust assessment of the presence of Mtbinfection in an individual wherein the individual is an immunocompromised person or a person co-infected with HIV.
    Type: Application
    Filed: November 15, 2016
    Publication date: May 23, 2019
    Applicant: Statens Serum Institut
    Inventors: Henrik Aggerbeck, Peter Lawætz Andersen, Morten Ruhwald